Nemysis Limited Signs With Kolinpharma SpA an IHAT Sales and Marketing Agreement
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Nemysis Limited Signs With Kolinpharma SpA an IHAT Sales and Marketing Agreement
trinidadtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from trinidadtimes.com Daily Mail and Mail on Sunday newspapers.
Nemysis Limited Signs Heads of Terms for IHAT Sales and Marketing
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Nemysis Ltd Announces Grant of First Chinese Patent for IHAT
Nemysis Ltd Announces Grant of First Chinese Patent for IHAT, the Novel Iron Nanoparticulate Supplement for Iron Deficiency (ID) and Iron Deficiency With Anemia (IDA).
News provided by
Share this article
Share this article
DUBLIN, May 12, 2021 /PRNewswire/ Nemysis Ltd today announced the issuance of China Patent Number 201680058940.3 titled Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses . This is the
first patent issued to Nemysis in China in the field of oral iron supplementation in conditions of ID and IDA. The patent claims describe methods for producing IHAT (Iron Hydroxide Adipate Tartrate), where Generally Recognised As Safe (GRAS) organic acids, and particularly Tartaric and Adipic acids, are used to modify the ferrihydrite nanocore of ferritin - the dietary and iron storage form of iron - increasing iron availability upon increased iron d